SK-575 is a highly effective PROTAC that selectively targets and degrades PARP1. Its structural design enables significant inhibition of cancer cell proliferation associated with BRCA1/2 mutations, showcasing its potential utility in studying cellular mechanisms influenced by PARP1 degradation.
Usually ships within 24 hours.